Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Intravitreal Autologous Platelet Concentrate Injection as an Adjunct of Vitrectomy for the Treatment of Refractory Macular Holes

NCT02081170 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT02081170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02081170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Intravitreal Autologous Platelet Concentrate Injection as an Adjunct of Vitrectomy for the Treatment of Refractory Macular Holes
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2013
Completion date
Not reported
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

large size macular hole (diameter > 600 microns) or, macular hole with high myopia (spherical equivalent ≤ -6.0 diopters) or,, or chronic macular hole (symptom duration > 6 months), recurred or failed macular hole from previous surgery